Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotine Pouches for Cigarette Substitution
NCT06595459Phase 4Recruiting
- Sponsor
- University of Wisconsin–Madison
- Start
- May 2025
- Primary completion
- Jan 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of nicotine in Tobacco Use Disorder (TUD) (4 arms), sponsored by University of Wisconsin–Madison. Primary endpoint: Mean number of cigarettes smoked per day at 3 weeks. Started May 2025; status: recruiting.
02
Drugs
nicotine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT06595459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06595459.